Skip to content

Clinical study of hormone replacement therapy for brain dead organ donors

Clinical study of hormone replacement therapy for brain dead organ donors

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068081
Enrollment
Unknown
Registered
2023-02-06
Start date
2023-02-15
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Organ donation donor maintenance

Interventions

Experimental group:hormone replacement therapy?Hormone replacement regimen: glucocorticoid + thyroxine + terresopressin + insulin
control group:Routine clinical treatment, including mechanical ventilation, fluid resuscitation, etc

Sponsors

Zhengzhou People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 18 years old < age <=60 years old, brain death criteria and circulatory instability. According to the Chinese brain death criteria and technical specifications, the criteria for brain death in this study were defined as follows: definite brain lesions, deep coma (Glasgow Coma scale 3), absence of spontaneous breathing, absence of brainstem reflexes, resting EEG and termination of cerebral circulation.

Exclusion criteria

Exclusion criteria: It does not meet the organ donation standards, and finally fails to meet the donation standards after donor maintenance (the donation standards are jointly evaluated and determined by experts organized by the OPO office of the hospital according to the guidelines for organ donation and acquisition in China), there are bloodstream infections, and other reasons are not complete for researchers.

Design outcomes

Primary

MeasureTime frame
The steady rate of compliance of the circulatory system;

Secondary

MeasureTime frame
Success rate of organ donation;Total fluid resuscitation volume (ml);Dosage and type of vasoactive drugs;Time from admission to acquisition (h);Time to reach cyclic stability;

Countries

China

Contacts

Public ContactWang Hongyu

Zhengzhou People's Hospital

hongyu260@163.com+86 136 7495 0311

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026